Jodie Yettram is a contributing writer at Cannabis Health, covering medical cannabis research, policy, patient access and clinical practice across the UK and Europe. An NCTJ Gold Standard, award-winning journalist from Jersey, her reporting has appeared across multiple Channel Island publications and City AM in London. She has a particular interest in women’s health, mental health and neurodiversity, having campaigned for improvements to women’s healthcare in her local paper and led an investigation into ADHD services. She also won the NCTJ’s Top Scoop award for breaking the news that Jersey’s home-birth service had been suspended.
Ahead of the Cannabis Health London Symposium next week, senior police drugs adviser Richard List warns of gaps in UK police knowledge of medical cannabis, while welcoming growing engagement and outlining plans for new driving guidance
Experts at the first Cannabis Health Symposium in Germany urged the industry to fund research into women’s pain, with an endometriosis specialist outlining plans for a new cannabis study and appealing for €300,000 for research.
BvCW president Dirk Heitepriem will speak in Frankfurt today about how lessons from across Europe could improve medical cannabis prescribing and patient care in Germany.
Lessons from medical cannabis markets across Europe will be explored at this week’s Cannabis Health Symposium in Frankfurt, with a focus on improving prescribing and patient care in Germany.
Copeia co-founder Garvin Hirt will join researchers in Frankfurt to discuss how politicians and doctors should make cannabis decisions when evidence is incomplete.
Has online prescribing improved medical cannabis care in Germany? Bertan Türemis will join a Frankfurt debate on telemedicine, prescribing standards and patient safety.
Researchers in Scotland are testing CBD for endometriosis and the lasting effects of chemotherapy, while European back-pain trials have helped bring a cannabis medicine to market. Cannabis Health looks at the studies, their findings and what comes next.
The European Medicinal Cannabis Association’s general secretary will join a debate on how research informs cannabis policy in less than two weeks time.
Changes to Germany’s health insurance rules have left patients facing new limits on funded cannabis treatment. Cannabis Health explains the rules and the industry’s objections.
Doctors, pharmacists and researchers will meet in Frankfurt on 4 November to discuss changes affecting medical cannabis treatment. With two weeks to go, here’s what’s on the programme and how to book…
Plans for greater scrutiny and monitoring have been broadly welcomed, but some patients fear a “knee-jerk” reaction and say cannabis is not the “whole story”.